Aims and Scope
Human Vaccines & Immunotherapeutics is a monthly peer-reviewed medical journal covering research into vaccines and immunotherapeutics in humans. It was established in 2005 as Human Vaccines, and obtained its current name in 2012. It is published by Taylor & Francis and the editor-in-chief is Ronald Ellis (FutuRx). According to the Journal Citation Reports, the journal had a 2013 impact factor of 3.643.
Key Metrics
5.5
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
80
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.83
5-Year SI
5-year SI
- 0.77 2-year SI
- 0.86 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Immunology
SJR
- Q2 Immunology
- Q1 Pharmacology
- Q2 Immunology and Allergy
- Q1 Medicine (miscellaneous)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.36
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Clinical trial
- Human papillomavirus
- Immunization
- Influenza vaccine
- Polysaccharide
- Streptococcus pneumoniae
- Immunotherapy
- Social media
- Performance improvement
- Measles
- Randomized controlled trial
- Burden of disease
- Rotavirus
- Public health
- Confidence interval
- Hepatitis B
- Seroconversion
- Virus
- Antigen
- Conjugate vaccine
Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS INC |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | EUR 2895 | GBP 2495 | USD 3175 |
| Publication Time | 11 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | International Society for Vaccines (ISV) |
| Frequency | Monthly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 11 |
| Article Processing Charges | EUR 2895 | GBP 2495 | USD 3175 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in Human Vaccines and Immunotherapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review
- 31 Dec 24
- Human Vaccines & Immunotherapeutics
-
Full paper
Recent progress in mRNA cancer vaccines
- 31 Dec 24
- Human Vaccines & Immunotherapeutics
-
Full paper
Economic burden of pertussis in children: A single-center analysis in Hangzhou, China
- 31 Dec 24
- Human Vaccines & Immunotherapeutics
-
Full paper
Enhancing vaccine effectiveness in the elderly to counter antibiotic resistance: The potential of adjuvants via pattern recognition receptors
- 31 Dec 24
- Human Vaccines & Immunotherapeutics
-
Full paper
Neutralizing activity of anti-respiratory syncytial virus monoclonal antibody produced in Nicotiana benthamiana
- 31 Dec 24
- Human Vaccines & Immunotherapeutics
-
Full paper
Knowledge, concerns, and vaccine acceptance related to Mpox (Monkeypox) among university students in North and Northeast China: An online cross-sectional study
- 31 Dec 24
- Human Vaccines & Immunotherapeutics
Scite analysis
Powered by scite_
5.9k articles received 79.6k citations see all
- 3,438 Supporting
- 73,510 Mentioning
- 546 Contrasting
Editorial notices
- 4 Retractions
- 0 Withdrawals
- 37 Corrections
- 36 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
31%
4 to 6 months
61%
7 to 9 months
6%
Above 9 months
2%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Human Vaccines and Immunotherapeutics been actively publishing?
Human Vaccines and Immunotherapeutics has been in operation since 2012 till date.
What is the publishing frequency of Human Vaccines and Immunotherapeutics ?
Human Vaccines and Immunotherapeutics published with a Monthly frequency.
How many articles did Human Vaccines and Immunotherapeutics publish last years ?
In 2023, Human Vaccines and Immunotherapeutics published 521 articles.
What is the eISSN & pISSN for Human Vaccines and Immunotherapeutics ?
For Human Vaccines and Immunotherapeutics,eISSN is 2164-554X and pISSN is2164-5515.
What is Citescore for Human Vaccines and Immunotherapeutics ?
Citescore for Human Vaccines and Immunotherapeutics is 5.5.
What is H index for Human Vaccines and Immunotherapeutics ?
H index for Human Vaccines and Immunotherapeutics is 80.
What is SNIP score for Human Vaccines and Immunotherapeutics ?
SNIP score for Human Vaccines and Immunotherapeutics is 1.36.
What is the SJR for Human Vaccines and Immunotherapeutics ?
SJR for Human Vaccines and Immunotherapeutics is Q1.
Who is the publisher of Human Vaccines and Immunotherapeutics ?
TAYLOR & FRANCIS INC is the publisher of Human Vaccines and Immunotherapeutics.